Dr. Jayant Raikhelkar, M.D
NPI: 1043417157
Total Payments
$11,580
2024 Payments
$1,477
Companies
24
Transactions
179
Medicare Patients
1,241
Medicare Billing
$225,042
Payment Breakdown by Category
Food & Beverage$10,226 (88.3%)
Travel$1,112 (9.6%)
Other$241.71 (2.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,226 | 168 | 88.3% |
| Travel and Lodging | $1,112 | 9 | 9.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $241.71 | 2 | 2.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $7,470 | 91 | $0 (2024) |
| Medtronic Vascular, Inc. | $1,140 | 10 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $599.39 | 27 | $0 (2024) |
| ABIOMED | $518.73 | 5 | $0 (2024) |
| United Therapeutics Corporation | $388.66 | 4 | $0 (2019) |
| Ancora Heart, Inc. | $388.00 | 1 | $0 (2021) |
| Bayer HealthCare Pharmaceuticals Inc. | $231.46 | 2 | $0 (2018) |
| Merck Sharp & Dohme LLC | $166.95 | 8 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $125.50 | 5 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $91.67 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,477 | 39 | Abbott Laboratories ($734.89) |
| 2023 | $1,591 | 22 | Abbott Laboratories ($1,272) |
| 2022 | $761.98 | 10 | Abbott Laboratories ($681.48) |
| 2021 | $800.05 | 5 | Abbott Laboratories ($393.51) |
| 2020 | $216.49 | 4 | Abbott Laboratories ($175.82) |
| 2019 | $845.18 | 18 | Medtronic Vascular, Inc. ($465.13) |
| 2018 | $2,276 | 34 | Abbott Laboratories ($1,375) |
| 2017 | $3,613 | 47 | Abbott Laboratories ($2,518) |
All Payment Transactions
179 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/13/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $21.22 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/12/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/11/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/04/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $147.87 | General |
| Category: Heart Failure | ||||||
| 11/23/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $10.28 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/22/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/08/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $23.44 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/02/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/30/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: DIABETES | ||||||
| 10/17/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $20.16 | General |
| Category: Cardiovascular | ||||||
| 09/26/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/24/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $135.77 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/21/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/11/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.93 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/09/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $170.91 | General |
| Category: Heart Failure | ||||||
| 09/06/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $20.88 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/22/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $10.84 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/20/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $124.63 | General |
| Category: Heart Failure | ||||||
| 08/07/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: Not Applicable | ||||||
| 07/24/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: DIABETES | ||||||
| 07/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: DIABETES | ||||||
| 06/14/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $145.83 | General |
| Category: Heart Failure | ||||||
| 06/07/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $17.44 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 05/17/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $21.91 | General |
| Category: Iron Deficiency Anemia | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 306 | 527 | $302,710 | $57,520 |
| 2022 | 9 | 340 | 617 | $330,650 | $63,253 |
| 2021 | 9 | 361 | 613 | $337,270 | $63,126 |
| 2020 | 9 | 234 | 424 | $207,395 | $41,143 |
Total Patients
1,241
Total Services
2,181
Medicare Billing
$225,042
Procedure Codes
36
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 88 | 186 | $98,580 | $20,627 | 20.9% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 38 | 96 | $96,720 | $18,779 | 19.4% |
| 93451 | Insertion of tube in right heart chambers for measurement | Facility | 2023 | 39 | 45 | $40,050 | $4,273 | 10.7% |
| 93505 | Biopsy of heart muscle | Facility | 2023 | 17 | 20 | $25,200 | $4,242 | 16.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 17 | 51 | $14,790 | $3,680 | 24.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 18 | 18 | $11,880 | $2,780 | 23.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 19 | 29 | $11,020 | $2,260 | 20.5% |
| 76937 | Ultrasonic guidance for blood vessel access | Facility | 2023 | 40 | 46 | $3,600 | $592.10 | 16.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 30 | 36 | $870.00 | $285.60 | 32.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 52 | 172 | $67,080 | $15,839 | 23.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 76 | 143 | $75,640 | $15,806 | 20.9% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 18 | 70 | $70,000 | $14,058 | 20.1% |
| 93505 | Biopsy of heart muscle | Facility | 2022 | 26 | 30 | $37,800 | $6,464 | 17.1% |
| 93451 | Insertion of tube in right heart chambers for measurement | Facility | 2022 | 51 | 60 | $53,400 | $5,647 | 10.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 20 | 20 | $13,200 | $3,115 | 23.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 17 | 23 | $8,740 | $1,522 | 17.4% |
| 76937 | Ultrasonic guidance for blood vessel access | Facility | 2022 | 48 | 56 | $3,920 | $682.36 | 17.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 32 | 43 | $870.00 | $118.32 | 13.6% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 33 | 94 | $93,760 | $16,954 | 18.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 70 | 143 | $69,990 | $16,931 | 24.2% |
| 93505 | Biopsy of the wall dividing the left and right heart | Facility | 2021 | 24 | 39 | $48,830 | $8,575 | 17.6% |
| 93451 | Insertion of catheter for diagnostic evaluation of right heart structures | Facility | 2021 | 57 | 76 | $67,400 | $7,217 | 10.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 35 | 64 | $24,960 | $6,000 | 24.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 21 | 21 | $13,860 | $3,375 | 24.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 19 | 35 | $11,780 | $2,926 | 24.8% |
About Dr. Jayant Raikhelkar, M.D
Dr. Jayant Raikhelkar, M.D is a Advanced Heart Failure and Transplant Cardiology healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/02/2007. The National Provider Identifier (NPI) number assigned to this provider is 1043417157.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jayant Raikhelkar, M.D has received a total of $11,580 in payments from pharmaceutical and medical device companies, with $1,477 received in 2024. These payments were reported across 179 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($10,226).
As a Medicare-enrolled provider, Raikhelkar has provided services to 1,241 Medicare beneficiaries, totaling 2,181 services with total Medicare billing of $225,042. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Ad
Practice Information
- Specialty Advanced Heart Failure and Transplant Cardiology
- Other Specialties Cardiovascular Disease, Advanced Heart Failure and Transplant Cardiology
- Location New York, NY
- Active Since 07/02/2007
- Last Updated 07/09/2019
- Taxonomy Code 207RA0001X
- Entity Type Individual
- NPI Number 1043417157
Products in Payments
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) $2,188
- Circulatory Support (Device) $1,591
- CardioMEMS HF System (Device) $1,380
- HeartMate 3 Left Ventricular Dev (Device) $1,139
- Claria MRI (Device) $546.85
- Impella (Device) $518.73
- CARDIOMEMS (Device) $500.71
- ENTRESTO (Drug) $472.27
- AccuCinch (Device) $388.00
- HeartWare HVAD (Device) $275.57
- HeartMate (Device) $269.57
- NONE (Drug) $241.71
- HeartMate 3 Left Ventricular Assist Device (Device) $240.99
- Adempas (Drug) $231.46
- Arctic Front (Device) $185.74
- MitraClip System (Device) $152.52
- Advisa (Device) $132.01
- VERQUVO (Drug) $127.74
- LEQVIO (Drug) $127.12
- LifeVest (Device) $125.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Advanced Heart Failure and Transplant Cardiology Doctors in New York
Prof. Johanna Contreras, M.d, Msc, M.D, MSC
Advanced Heart Failure and Transplant Cardiology — Payments: $578,636
Advanced Heart Failure and Transplant Cardiology $578,636
Dr. Gabriel Sayer, M.d, M.D
Advanced Heart Failure and Transplant Cardiology — Payments: $75,985
Advanced Heart Failure and Transplant Cardiology $75,985
Dr. Paolo Colombo, M.d, M.D
Advanced Heart Failure and Transplant Cardiology — Payments: $54,206
Advanced Heart Failure and Transplant Cardiology $54,206
Kelly Axsom, Md, MD
Advanced Heart Failure and Transplant Cardiology — Payments: $42,770
Advanced Heart Failure and Transplant Cardiology $42,770
Dr. Michael Divita, M.d, M.D
Advanced Heart Failure and Transplant Cardiology — Payments: $29,710
Advanced Heart Failure and Transplant Cardiology $29,710
David Majure, M.d., M.p.h, M.D., M.P.H
Advanced Heart Failure and Transplant Cardiology — Payments: $16,680
Advanced Heart Failure and Transplant Cardiology $16,680